INTRODUCTION
Neurodegenerative disorders are increasingly prevalent in our society and represent a very significant challenge to healthcare systems (Balch et al., 2008; Dobson, 2003) . A number of explanations of the fundamental origins of these diseases have been proposed, including mitochondrial dysfunction, disruptions of the endoplasmic reticulum and membrane trafficking, effects on protein folding and clearance, and the activation of inflammatory responses (Balch et al., 2008; Dobson, 2003; Querfurth and LaFerla, 2010; Selkoe, 2011) . One common feature associated with these conditions, however, is the aggregation of certain peptides and proteins, which generates a cascade of pathological events, including the secondary aggregation of various other proteins and the consequent failure of protein homeostasis to preserve normal biological function (Balch et al., 2008; Dobson, 2003; Gidalevitz et al., 2006; Selkoe, 2011) .
Given the evidence that protein aggregation is a widespread phenomenon (Chapman et al., 2006; David et al., 2010; Gidalevitz et al., 2006; Koga et al., 2011; Koplin et al., 2010; Liao et al., 2004; Narayanaswamy et al., 2009; Olzscha et al., 2011; Reis-Rodrigues et al., 2012; Wang et al., 2005; Xia et al., 2008) , two key questions are why some proteins, but not others, aggregate in vivo and generate pathological states, and whether or not the identities of these proteins differ substantially between diseases. If particular proteins aggregate in response to specific stresses, different sets of aggregated proteins will appear under each condition. Alternatively, the various sets of aggregating proteins may correspond to a fraction of the proteome with distinctive characteristics that increase the risk of aggregation under many kinds of stress. The latter possibility is consistent with observations that aggregation-prone proteins share general physicochemical features (Chiti et al., 2003; Fernandez-Escamilla et al., 2004; Olzscha et al., 2011; Tartaglia et al., 2008) .
Our aim in this work has been to answer a fundamental question about widespread protein aggregation: why certain proteins aggregate in stress, aging, or disease, whereas others do not. To address this problem, we have sought to establish a proteomewide method of identifying the proteins that are vulnerable to aggregation in vivo. Using this method, we have identified a number of proteins that are expressed at levels that are high relative to their solubilities. These proteins are supersaturated because their concentrations exceed their solubility levels. Early evidence that supersaturation predisposes proteins to aggregate was provided by the finding that the rate and extent of aggregation of hemoglobin S, which is associated with sickle cell anemia, are strongly concentration dependent (Hofrichter et al., 1976) . More recently, this idea has been used to compare the aggregation and crystallization behavior of proteins (Yoshimura et al., 2012) . Here, we have extended the concept of supersaturation to the proteome level by considering both the unfolded and folded states that can be populated by individual proteins, as well as their association into complexes. Thus, for example, an intrinsically aggregation-prone protein is not necessarily dangerous unless it is expressed at a relatively high concentration. Similarly, a highly concentrated protein may not be at risk of losing its solubility unless its intrinsic propensity to aggregate is relatively high.
By predicting supersaturation from estimated protein concentrations and aggregation propensities at a proteome scale, we are able to rationalize a variety of phenomena associated with aggregation and misfolding diseases. We find through our analysis of the human and C. elegans proteomes that those proteins known to interact with aggregates or to aggregate upon aging are highly supersaturated and that the cellular processes known to be associated with neurodegenerative diseases are at risk of disruption because they involve an exceptionally large number of supersaturated proteins. These results show how the initial appearance of protein aggregates in the presence of other vulnerable proteins can precipitate a series of uncontrolled aggregation events with severe pathological consequences and that proteins in a supersaturated state comprise the subproteome most at risk of misfolding and aggregation under conditions of stress. These proteins and the biochemical pathways to which they belong may be the first to suffer from an impairment of protein homeostasis and, therefore, represent the underlying basis for the cellular damage caused by diseases of misfolding, including neurodegenerative conditions such as Alzheimer's, Huntington's, and Parkinson's diseases.
RESULTS

Prediction of Protein Supersaturation from Concentration and Aggregation Propensity
In order to identify those proteins most at risk of misfolding and aggregating in vivo, we calculated their level of supersaturation using a score that we define in terms of the concentrations of proteins relative to their aggregation propensities (see Experimental Procedures; Supplemental Experimental Procedures). The cellular concentrations of proteins with high supersaturation scores are more likely to exceed their critical values under varying conditions, leading these proteins to become insoluble. We here used the aggregation propensities of proteins as estimates of their solubility because experimental measurements of critical concentrations of proteins in vivo are extremely difficult to carry out at the proteome level. To evaluate the risk of proteins to aggregate from their unfolded or native states, we define the parameters s u and s f as the supersaturation scores, respectively (Figure 1 ). The risk of aggregation is different in these two states because in the folded state the most aggregation-prone regions tend to be buried in the core of the structure, and thus they are prevented from forming intermolecular interactions (Tartaglia et al., 2008) . The critical concentrations of proteins in their unfolded states thus are generally expected to be lower than in their folded states, hence the necessity of introducing the s u and s f scores separately. Because the largest pool of unfolded proteins corresponds to newly synthesized proteins, whose concentrations can be estimated from the corresponding mRNA concentrations, we used the logarithmic average of scores derived from microarray analysis of over 70 types of human tissue or of the nematode C. elegans at a range of ages to represent levels of newly synthesized proteins (Golden et al., 2008; Su et al., 2004) . For folded proteins, in order to define the s f score, we used the logarithm of the normalized spectral abundance factors (NSAFs) derived from mass spectrometry (Schrimpf et al., 2012) .
We estimated the propensity of proteins to aggregate from the unfolded state using the Z agg score calculated with the Zyggregator method (Tartaglia et al., 2008) , which is based on the analysis of the physicochemical properties of amino acid sequences (Chiti et al., 2003) . The Zyggregator method employs algorithms that have been parameterized to reproduce the aggregation behavior of a set of known amyloidogenic proteins and has been validated in a series of studies in which it has been shown to lead to accurate predictions of aggregation rates both in vitro and in vivo (Belli et al., 2011; Luheshi et al., 2007; Roodveldt et al., 2012; Tartaglia et al., 2008) . For proteins that aggregate from the native state, we used an aggregation propensity score that accounts for the protective effects of the folded structure, which is defined by assigning corrections to the aggregation propensities of individual residues on the basis of the extent of the structural fluctuations that they experience in the folded state and that lead to their temporary exposure to the solvent (Tartaglia et al., 2008) . This structurally corrected aggregation propensity score (Z SC agg ) has been shown to correlate well with protein solubility determined from an in-vitro-reconstituted bacterial ribosome system (Agostini et al., 2012) . We then summed the logarithms of the concentration and aggregation propensity values (see Experimental Procedures; Supplemental Experimental Procedures) to construct a human database of s u scores for 16,263 proteins and s f scores for 6,155 proteins, and a C. elegans database of s u scores for 16,623 proteins and s f scores for 10,149 proteins (Table S2 ). The sizes of our databases were limited primarily by the availability of expression and Proteins may misfold and aggregate as they emerge from the ribosome or when they unfold at least transiently from the native state. The proteins most at risk for aggregation are those whose concentrations are high with respect to their solubilities. We quantify this risk by defining the supersaturation s u and s f scores. The supersaturation score s u , which measures the tendency of proteins to aggregate from the unfolded state, is based on the Zyggregator score (Tartaglia et al., 2008) abundance data that could be unambiguously mapped to specific protein identifiers.
Supersaturation Scores Rationalize Widespread Protein Aggregation under Stress
Because a wide range of proteins is known to form fibrillar assemblies within the cell (Chapman et al., 2006; Chiti and Dobson, 2006; David et al., 2010; Fowler et al., 2007; Gidalevitz et al., 2006; Haass and Selkoe, 2007; Hartl et al., 2011; Koplin et al., 2010; Liao et al., 2004; Olzscha et al., 2011; Reis-Rodrigues et al., 2012; Wang et al., 2005; Xia et al., 2008) , we investigated the relationship between the phenomena of supersaturation and aggregation. For instance, the function of actin, a highly abundant protein also identified as being highly supersaturated in our calculations (Table S2) , relies on its ability to assemble reversibly into filaments, and it has been suggested that given . We compared the supersaturation scores s f for (B) the whole proteome and the human ''amyloid proteins'' in UniProt (UniProt Consortium, 2012), (C) the whole proteome and proteins that coprecipitate in amyloid plaques (Liao et al., 2004) , (D) the whole proteome and proteins that coprecipitate in neurofibrillary tangles (NFTs) (Wang et al., 2005) , (E) the whole lysate and proteins that coprecipitate in Lewy bodies (Xia et al., 2008) , (F) the whole lysate and proteins that coprecipitate in artificial b sheet protein aggregates (Olzscha et al., 2011) , and (G) the whole proteome and proteins found to aggregate in C. elegans during aging (David et al., 2010; Reis-Rodrigues et al., 2012) . Boxplots extend from the lower to the upper quartiles, with the internal lines referring to the median values. Whiskers range from the lowest to highest value data points within 150% of the interquartile ranges. The statistical significance was assessed by the Wilcoxon/Mann-Whitney U test with Bonferroni-corrected p values (*p < 0.05, **p < 0.01, and ****p < 0.0001). See also Figures S1-S3, S5, and S6.
the typical cytosolic concentration of actin, it would always remain in a polymerized form were it not for the presence of specific regulatory mechanisms (Pollard et al., 2000) .
More generally, we find that the ''amyloid proteins,'' as annotated in the UniProt database (UniProt Consortium, 2012), have elevated supersaturation scores ( Figures 2A, 2B , S1A, S1B, S1H, and S1I). For these proteins, the s f score is more than 500-fold greater than the median value over the proteome (5403, p = 1.9 3 10 À5 ), indicating that these proteins are on average at greater risk for aggregation upon accumulation in the cell (Figures 2A and 2B ) than when they are in the process of being synthesized (Figures S1A and S1B). This conclusion is consistent with the appearance of such proteins as the predominant constituents of either intracellular inclusions or extracellular deposits in a variety of diseases (Balch et al., 2008; Dobson, 2003) . Given that high supersaturation scores correspond to an increased risk of proteins becoming insoluble, we investigated whether such scores can rationalize additional aspects of protein aggregation, including coaggregation with large, insoluble deposits associated with disease (Liao et al., 2004; Wang et al., 2005; Xia et al., 2008) and artificial b sheet protein (Olzscha et al., 2011) aggregates. Our results indicate that the s f score can identify proteins found to incorporate into amyloid plaques (Liao et al., 2004) with observations from pulse-chase experiments that both newly synthesized and preexisting proteins interact with aggregates (Olzscha et al., 2011) . The s f (Figure 2 ) and s u ( Figure S1 ) scores are broadly consistent for all of these sets, with proteins that coaggregate with large inclusions tending to be relatively highly supersaturated in both the folded and unfolded states.
We then turned our attention to the analysis of proteins that are likely to become susceptible to aggregation when the control of protein homeostasis declines, as in aging (David et al., 2010; Reis-Rodrigues et al., 2012) . We observe that the s u scores (0.613, p = 2.0 3 10 À85 , Figures S1A and S1G) of proteins that aggregate upon aging in C. elegans (David et al., 2010; ReisRodrigues et al., 2012) are lower than those of the proteome as a whole; by contrast, the s f scores are much higher for these proteins (353, p = 1.9 3 10 À158 , Figures 2A and 2G) . The low values of the s u scores can be attributed to the fact that global gene expression in C. elegans declines with age (Golden et al., 2008) , thus reducing the levels of newly synthesized proteins that may aggregate from their unfolded states. Instead, proteins that aggregate during aging have low expression levels but relatively high concentrations and tend to be metastable by virtue of their high s f scores.
Because both the estimates of concentration and the predictions of aggregation propensity are subject to considerable potential errors, to test the robustness of our results against these errors, we introduced Gaussian noise into the calculations of the s f and s u scores, finding that the results are indeed stable against high levels of noise (in many cases, more than 50-fold error, Figures S2 and S3 ).
Biochemical Pathways Associated with Neurodegenerative Diseases Are Enriched in Supersaturated Proteins
Because supersaturation scores are able to explain diverse phenomena related directly to aggregation, we wondered whether they might help identify cellular processes particularly sensitive to stress. Therefore, we asked whether particular biochemical pathways are at high risk for disruption by virtue of the supersaturation levels of their constituent proteins. For our analysis, we considered the pathways that are listed in the Kyoto Encyclopedia of Genes and Genomes (KEGG), which are based on manually curated sets of proteins involved in cellular processes or proposed to be involved in disease on the basis of reports in the literature. We used the DAVID software (Huang et al., 2009) to determine if any of the KEGG pathways (Kanehisa et al., 2010) have a large number of human proteins with high s u or s f scores. We carried out an unbiased search of the roughly 200 KEGG pathways and found only 8 pathways significantly enriched in the proteins with s u scores at or above the 95 th percentile. Strikingly, all these pathways involve proteins that either form well-defined functional complexes or are related to diseases that involve pathological protein complexes. The three disease pathways that are most dramatically enriched in supersaturated proteins are those of Alzheimer's (p = 6.0 3 10 À17 ),
Parkinson's (p = 1.1 3 10 À28 ), and Huntington's (p = 4.0 3 10
À22
) diseases ( Figure 3A) . A fourth pathway, involved in pathogenic E. coli infection, which is closely associated with the cytoskeleton, is also enriched but to a much less significant level (p = 4.6 3 10
À3
). KEGG pathways are broadly constructed, with those related to neurodegenerative diseases including not only proteins known to aggregate but also the proteins that process these aggregates and the cellular systems that become impaired as a result of aggregation (Kanehisa et al., 2010) . Despite this disparate collection of proteins, a staggering twothirds of proteins in the KEGG Alzheimer's disease pathway have supersaturation scores above the median value for the human proteome (Figure 4) .
In addition to these disease pathways, we also find that the KEGG pathways associated with the assembly of the ribosome (p = 4.0 3 10
À53
) and the proteasome (p = 3.2 3 10 À2 ), and The KEGG pathway for Alzheimer's disease (Kanehisa et al., 2010) is curated from the literature and includes many proteins not directly associated with the disruption of the homeostasis of the Ab peptide. Those proteins that are part of the overlap (see Figure 5A ) of the Alzheimer's, Parkinson's, and Huntington's disease pathways are shown in bold. Approximately 65% of proteins in the Alzheimer's pathway have high s u scores. Colors are assigned based on the division of the s u database into deciles from low (green) to high (red).
with the processes of oxidative phosphorylation (p = 8.8 3 10 À33 )
and cardiac muscle contraction (p = 3.9 3 10 À5 ), are enriched in supersaturated proteins ( Figure 3A ). These results, particularly those associated with the ribosome and oxidative phosphorylation, are highly robust against errors in the calculation of s u scores ( Figure 3B ). All of these pathways involve the assembly of major cellular macromolecular complexes, the components of which must contain interactive surfaces that tend to be aggregation prone (Pechmann et al., 2009 ). In agreement with this finding, proteins involved in such assemblies, especially the ribosome, have been observed consistently in widespread aggregation studies (David et al., 2010; Koplin et al., 2010; Reis-Rodrigues et al., 2012) . Significantly, none of the pathways identified by using supersaturation scores is identifiable from aggregation propensities alone. These results suggest that widespread aggregation under conditions of stress is defined not only by the specific nature of the stress itself but also by the level of supersaturation of the proteins that aggregate. If this is the case, some proteins should have characteristics that render them susceptible to aggregation under a variety of conditions. To investigate this possibility, we determined the overlap among the Alzheimer's, Parkinson's, and Huntington's disease KEGG pathways. The 76 proteins common to the pathways represented by these diseases have on average a much larger s u score (193, p = 4.2 3 10 À31 ) than that of the proteome as a whole (Figure 5A ), or indeed, that of the remaining proteins in the three individual pathways ( Figure 5B ).
Of the eight pathways enriched in proteins with high s u scores, five, including those for Alzheimer's, Parkinson's, and Huntington's diseases, are also enriched in proteins with high s f scores, although in the latter case, the data are less statistically significant ( Figure S4 ). The fact that the s u scores so strongly single out pathways involved in neurodegeneration suggests that the proteins that misfold and aggregate during the course of these diseases aggregate primarily from unstructured or partially unstructured states. In particular, because many proteins in the KEGG neurodegenerative disease pathways are membrane proteins, they are unlikely to aggregate from their folded state in the membrane environment. They are, however, likely to be at risk during folding or upon removal from the membrane for degradation (MacGurn et al., 2012; Notterpek et al., 1999; Skach, 2009) , especially if protein homeostasis dysfunction impairs membrane trafficking, as has been reported by Cooper et al. (2006) . Consistent with the view that membrane proteins may have a somewhat elevated risk of aggregation in the unfolded state is that the median s u score is modestly elevated for proteins with ''membrane'' Gene Ontology (Ashburner et al., 2000) tag (1.23, p = 1.7 3 10 À20 ), whereas the s f score is low for such proteins (0.473, 5.9 3 10 À52 ). This risk, therefore, is small compared to that of most sets of aggregating proteins in Figure 2 . In order to test whether or not the observation that the Alzheimer's, Parkinson's, and Huntington's disease pathways have elevated numbers of supersaturated proteins is simply a consequence of their richness in membrane proteins, we determined whether or not the sets of proteins at or above the 95 th percentile of s u or s f scores are significantly enriched in membrane proteins compared to the proteome at large. Our results indicate that the most supersaturated proteins are not enriched in this way (s u : p = 0.16, s f : p = 1.0). However, we do find that the proteins most supersaturated in the unfolded state are enriched in those associated with the Gene Ontology tag ''organelle membrane'' (s u : p = 6.9 3 10
À19
, s f : p = 1.0). This result is consistent with recent evidence that membrane proteins in the mitochondrial respiratory chain can misfold when the Parkinson's-associated gene PINK1 is mutated (Pimenta de Castro et al., 2012) . In fact, predominant among the overlapping proteins in the Alzheimer's, Parkinson's, and Huntington's disease pathways are the proteins that are members of the respiratory chain.
Because coaggregating proteins are more highly supersaturated in the folded state than in the unfolded state, the ability of the s u score, in addition to the s f score, to identify disease pathways suggests at least three possibilities. First, it may be that many proteins involved with disease aggregate independently instead of associating with inclusions, as suggested by the tendency of proteins toward homomeric aggregation (Matsumoto et al., 2006; Rajan et al., 2001; Wright et al., 2005) . Second, proteins involved with disease may be degraded if they fail to fold into their native conformation (Goldberg, 2003) . Third, because mass spectrometry experiments designed to identify aggregating or coaggregating proteins tend to ignore membrane proteins because of the difficulty of distinguishing them from truly insoluble ones, these experiments may be missing an important component of the disease process. Despite the need for such details to be resolved in the future, our results suggest that supersaturation in the folded state is reporting on significant functional properties of proteins in the cell, as well as on potentially pathological processes. We find, for example, that in addition to proteins that aggregate (Figure 2 , Figure 6 ). These results are consistent with evidence that the features that mediate normal protein interactions are similar to those that promote aggregation (Pechmann et al., 2009) .
To test our results for the s u scores, we used another predictor of aggregation from the unfolded state, the TANGO algorithm (Fernandez-Escamilla et al., 2004) . A supersaturation score based on this algorithm (s uT ) (Table S2) produces similar results to those obtained with the s u score ( Figure S1 ). Furthermore, to test the possibility that the s u and s f scores may give too much weight to the expression levels relative to the aggregation propensities, we increased the exponential weight of aggregation propensities in the s u and s f score. At the highest reweighting that we tested ( Figures S5 and S6) , supersaturation scores are more strongly correlated with aggregation propensity (human Z agg , s u : 0.88; human Z SC agg , s f : 0.88; worm Z agg , s u : 0.99; and worm Z SC agg , s f : 0.96) than concentration score (human mRNA expression, s u : 0.35; human protein abundance,s f : 0.53; worm mRNA expression, s u : 0.10; and worm protein abundance,s f : À0.015). We find that most of our results are robust over a wide range of weights for the aggregation propensity ( Figures S5 and S6) .
Nevertheless, we observed that concentration is a strong predictor of the variety of aggregation-related phenomena that we have analyzed in this work because an important component of the predictive power of s f is attributable to this property. Indeed, the widespread aggregation data sets that we considered tend to exhibit protein abundance levels more elevated than corresponding mRNA levels, and whereas they also tend to be more elevated in Z SC agg than Z agg , the difference is much smaller ( Figure S1 ). In addition, the ratio of relative s f -to-s u values is positively correlated with the ratio of relative protein abundance-to-mRNA levels but negatively correlated with the ratio of relative Z SC agg -to-Z agg levels ( Figure S1 ). The relevance of the concentration levels in rationalizing widespread aggregation measurements is a further indication that the concepts of solubility and supersaturation are key in understanding these data.
Moreover, because both the procedures adopted for pathway construction in the KEGG database (Kanehisa et al., 2010) and the identification of aggregating proteins using mass spectrometry (Olzscha et al., 2011) typically consider only the more abundant proteins, the use of the supersaturation score helps to identify additional proteins that aggregate in disease, particularly those with low concentrations and high aggregation propensities. For example, pathways related to cell surface receptors, including olfactory transduction (p = 4.0 3 10 À90 ) and neuroactive ligand-receptor interaction (p = 4.9 3 10 À5 ), are enriched among those supersaturated proteins that are present at low concentrations.
DISCUSSION
Previous studies that have investigated the causes of proteomewide aggregation have considered the intrinsic aggregation propensities of proteins (Goldschmidt et al., 2010; Monsellier et al., 2008; Tartaglia et al., 2005; Tartaglia and Vendruscolo, 2010) . It has thus been suggested that a diverse collection of proteins can form aggregates, although the presence of molecular chaperones and clearance processes largely prevents proteome-wide aggregation under stress-free conditions (Dobson, 2003; Goldschmidt et al., 2010; Lindquist and Kelly, 2011; Monsellier et al., 2008; Olzscha et al., 2011) . It has also been shown that destabilizing mutations may drive soluble proteins toward aggregation and that a genetic background predisposed to such defects can exacerbate this problem (Gidalevitz et al., 2006; Luheshi et al., 2007) . More generally, because protein aggregation in the cellular environment has potentially devastating effects, the expression of aggregation-prone proteins is generally maintained at low levels and tightly regulated (Gsponer and Babu, 2012) . It has been observed, however, that proteins are only just soluble at the levels at which they are expressed in the cell and because these trends are conserved in the yeast, mouse, and human proteomes, it has been suggested that monomeric and aggregated forms of proteins are in an effective homeostatic state (Gsponer and Babu, 2012) . Similarly, it was recently shown that highly abundant proteins have fewer aggregation-prone surfaces, an observation consistent with their low aggregation propensities (Levy et al., 2012; Tartaglia et al., 2007) . Given these evolutionary constraints, it may be surprising that in vivo aggregation is such a common phenomenon under stress (Chapman et al., 2006; Gidalevitz et al., 2006; Koplin et al., 2010; Liao et al., 2004; Narayanaswamy et al., 2009; Olzscha et al., 2011; Wang et al., 2005; Xia et al., 2008) or aging (David et al., 2010; Koga et al., 2011; Reis-Rodrigues et al., 2012) . Our results on protein supersaturation provide an explanation for these observations because they indicate that not only the intrinsic propensities of proteins to aggregate but also their cellular concentrations are key factors that distinguish aggregation-prone proteins from those whose homeostasis is more robust (Tables 1 and S2 been observed that widespread aggregation occurs upon overexpression, which raises the supersaturation levels (Gsponer and Babu, 2012; Narayanaswamy et al., 2009; Sopko et al., 2006) , our results indicate that a substantial fraction of the proteome is intrinsically supersaturated and therefore requires the constant aid of quality control mechanisms such as molecular chaperones to remain soluble. The example of serum albumin illustrates some of the strategies adopted by supersaturated proteins to avoid aggregation, as well as their limitations. Albumin, which is exceptionally abundant, is classified in our analysis as supersaturated (Table S2) . This protein, which is ubiquitous in the serum, is usually considered to be very soluble, and yet it has been observed to aggregate in vitro (Costantino et al., 1995; Maruyama et al., 2001) and to form toxic aggregates in the synovial fluid of patients with rheumatoid arthritis (Oates et al., 2006) . These findings reflect two important aspects that regulate the behavior of supersaturated proteins: the volume that they occupy, and the interactions that they form. Although albumin is highly abundant in the serum, its concentration is still relatively low owing to the large volume of the serum itself. By contrast, when confined in the synovial fluid, which has a smaller volume, the concentration of albumin may become substantially higher. In addition, albumin forms numerous complexes with proteins and other molecules, which may protect it from aggregation, as has been observed for the ribosomal proteins (David et al., 2010; Koplin et al., 2010; Reis-Rodrigues et al., 2012) . Future studies should account for the volume occupied by proteins and the complexes they form in order to increase the accuracy of supersaturation predictions.
Although abundant proteins have evolved to be more soluble than those that are of low abundance , some proteins are expressed at such high concentrations that it may be impossible for them to achieve the necessary solubility with the constraints of functionality and the need for a stable hydrophobic core. We have indeed found that abundance itself is also a good predictor of widespread aggregation in vivo. This result indicates that highly abundant proteins are intrinsically more at risk of aggregation than low-abundant proteins (Table S3), which in turn suggests that highly abundant proteins must be maintained at high solubility levels by the protein homeostasis system. These proteins are therefore more susceptible to aggregation in processes that impair protein homeostasis, such as stress, aging, or disease. The strong predictive power of abundance underscores the importance of solubility in this phenomenon.
Supersaturated proteins are kinetically, but not thermodynamically, stable in their soluble states (Baldwin et al., 2011; Gazit, 2002; Yoshimura et al., 2012) and are, thus, likely to be highly dependent on the systems that control protein homeostasis in order to remain soluble. The instability of supersaturated proteins is thus expected to arise from the failure of cellular systems that contribute to keeping them soluble. The disruption of this machinery under stress and in disease conditions leads to the aggregation of such proteins by shifting the protein homeostasis boundary for their solubility (Hutt et al., 2009; Taylor and Dillin, 2011) . The present study suggests that a widespread failure to maintain proteins in their soluble functional states underlies the diverse and complex pathophysiology of neurodegenerative diseases. The sensitivity of neurons to protein aggregation, therefore, may arise from their high dependence on classes of proteins, such as those identified here, that are inherently and unavoidably at risk. Thus, the initial aggregation of the primary amyloid proteins, such as Ab and a-synuclein, may trigger an aggregation cascade that disrupts cellular pathways involving these supersaturated proteins. ''Data Set'' is a description of the data used. ''References'' indicate the references for the data. ''Species'' indicates the species to which the data refer. ''Original Number'' is the number of data points listed in the original published set. ''Number of UniProt IDs'' is the number of data points listed after conversion to UniProt ID. For human proteins, only the reviewed UniProt IDs are counted. No. s u , no. s f , and no. s uT are the number of those proteins in the Number of UniProt IDs column, the number for which the given score is available. See also Table S1 .
In conclusion, we have shown that the presence of a large number of supersaturated proteins in the human proteome rationalizes a wide variety of aggregation phenomena associated with aging and disease. The finding that such proteins are overrepresented in a broad range of biochemical processes linked to neurodegenerative diseases reveals why such processes are particularly vulnerable to the appearance of aggregated species or other factors that compromise proteins homeostasis. We anticipate that the type of analysis that we have described can provide a general and widely applicable basis for tracking the instability of proteomes under specific circumstances. By exploiting recent advances in techniques for proteomic analysis, it may soon become possible to use supersaturation measures to assess quantitatively the vulnerability of the human proteome to aggregation and the risk of neurodegenerative disease in individuals over the course of their lives.
EXPERIMENTAL PROCEDURES
The concentration and aggregation propensity of a given protein were combined to produce the supersaturation score s = C + Z, where C is the logarithm of the concentration derived from the mRNA expression or protein abundance levels (see Tables S1 and S2) , and Z is the Zyggregator score. The s scores were then recentered such that the median of each database was zero and used to analyze proteins associated with widespread aggregation (Chapman et al., 2006; David et al., 2010; Gidalevitz et al., 2006; Koplin et al., 2010; Liao et al., 2004; Olzscha et al., 2011; Reis-Rodrigues et al., 2012; Wang et al., 2005; Xia et al., 2008) , by comparing them to a control lysate when available, or to the full proteome database otherwise. Similar procedures were followed for protein complexes (Licata et al., 2012; Luc and Tempst, 2004) . A summary of data sets used in this study is provided in Tables 1 and S2 . DAVID (Gidalevitz et al., 2006 ) was used to find KEGG (Kanehisa et al., 2010) pathways enriched in proteins at or above the 95 th percentile of each s score, with the full database set as background. Error tests were performed by introducing Gaussian noise into the full s u and s f databases in 100 independent trials or by changing the weighting of aggregation propensity in the uncentered scores, and then recomputing Mann-Whitney U p values and median fold changes each time.
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